Patents by Inventor Jin-kyo Jeong

Jin-kyo Jeong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230130510
    Abstract: Disclosed herein is a method for manufacturing a hydrogen sensor, the method comprising the steps of: disposing a thin film made of a transition metal or an alloy thereof on a surface of elastic substrate; applying a tensile force in a repetitive manner to the elastic substrate to form a nanocrack on the thin film disposed on the surface of the elastic substrate; and injecting hydrogen gas into the formed nanocrack and then removing the hydrogen gas to form a nanogap, wherein the tensile force in the step of forming a nanocrack is applied to an extent that the elastic substrate has a tensile strain of 25% to 100%.
    Type: Application
    Filed: June 21, 2022
    Publication date: April 27, 2023
    Inventors: Dong Gu Kim, Jang Hyeon Lee, Dae Sung Kwon, Hyun Soo Kim, Il Seon Yoo, Tae Ho Jeong, Woo Young Lee, Hyun Sook Lee, Se Young Park, Soo Min Lee, Jin Kyo Jeong, Hae Won Yoon
  • Publication number: 20200044268
    Abstract: A redox flow battery including a plurality of electrically connected stacks is provided. A plurality of stacks are alternately connected by electrical connecting lines, with at least one stack therebetween.
    Type: Application
    Filed: September 28, 2017
    Publication date: February 6, 2020
    Inventors: Hyeon-Seok JANG, Dae-Sik KIM, Dong Hwa HAN, Jin Kyo JEONG, Dong Kyun SEO
  • Patent number: 10239902
    Abstract: The present invention provides a stable peptide-conjugated, ascorbic acid derivative, a method for preparing the same, and a cosmetic composition comprising the same as an active ingredient. The stable peptide-conjugated ascorbic acid derivative of the present invention has both the effect of whitening the skin by inhibiting melanin production and the effect of reducing skin wrinkles by activating collagen production, and may be used in a cosmetic composition.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: March 26, 2019
    Assignee: CELLTRION INC.
    Inventors: Young Jun Park, Jung Yun Kim, Jin Kyo Jeong, Hyeong Mi Kim, Eun Joo Cho, Joo Hyuck Lim, Hyun Nam Song, Seon Kyung Park, Won Kang Moon, Shin Jae Chang, Seung Suh Hong
  • Patent number: 9814784
    Abstract: The present invention relates to an antibody-linker-drug conjugate in which an antibody and a cytotoxic drug are conjugated through an enzyme cleavable peptide linker capable of directly binding to a lysine residue of an antibody, a preparation method therefor, and an anticancer drug composition containing the same as an active ingredient.
    Type: Grant
    Filed: January 2, 2014
    Date of Patent: November 14, 2017
    Assignee: CELLTRION, INC.
    Inventors: Young Jun Park, Jin-kyo Jeong, Young Mi Choi, Minseob Lee, Yeon Jung Kim, Kyoung Suk Kim, Joon hun Choi, Jin Seo Lee, Eun Joo Cho, Hyunnam Song, Sung Jun Park, Jong-hyoup Lee, Matthew Sangyup Lee, In-Suk Lee, Joon woo Kim, Seung Suh Hong
  • Publication number: 20170258931
    Abstract: The present invention provides a stable peptide-conjugated, ascorbic acid derivative, a method for preparing the same, and a cosmetic composition comprising the same as an active ingredient. The stable peptide-conjugated ascorbic acid derivative of the present invention has both the effect of whitening the skin by inhibiting melanin production and the effect of reducing skin wrinkles by activating collagen production, and may be used in a cosmetic composition.
    Type: Application
    Filed: May 26, 2017
    Publication date: September 14, 2017
    Applicant: CELLTRION INC.
    Inventors: Young Jun Park, Jung Yun Kim, Jin Kyo Jeong, Hyeong Mi Kim, Eun Joo Cho, Joo Hyuck Lim, Hyun Nam Song, Seon Kyung Park, Won Kang Moon, Shin Jae Chang, Seung Suh Hong
  • Patent number: 9278996
    Abstract: The present invention provides a dolastatin-10 derivative having excellent anticancer activity, a method of producing the same and anticancer drug composition containing the same as an active ingredient.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: March 8, 2016
    Assignee: CELLTRION, INC.
    Inventors: Young Jun Park, Jin-kyo Jeong, Young Mi Choi, Min Seob Lee, Joon hun Choi, Eun Joo Cho, Hyunnam Song, Sung Jun Park, Jong-hyoup Lee, Seung Suh Hong
  • Publication number: 20150366990
    Abstract: The present invention relates to an antibody-linker-drug conjugate in which an antibody and a cytotoxic drug are conjugated through an enzyme cleavable peptide linker capable of directly binding to a lysine residue of an antibody, a preparation method therefor, and an anticancer drug composition containing the same as an active ingredient.
    Type: Application
    Filed: January 2, 2014
    Publication date: December 24, 2015
    Inventors: Young Jun PARK, Jin-kyo JEONG, Young Mi CHOI, Minseob LEE, Yeon Jung KIM, Kyoung Suk KIM, Joon hun CHOI, Jin Seo LEE, Eun Joo CHO, Hyunnam SONG, Sung Jun PARK, Jong-hyoup LEE, Matthew Sangyup LEE, In-Suk LEE, Joon woo KIN, Seung Suh HONG
  • Publication number: 20150225455
    Abstract: The present invention provides a dolastatin-10 derivative having excellent anticancer activity, a method of producing the same and anticancer drug composition containing the same as an active ingredient.
    Type: Application
    Filed: September 16, 2013
    Publication date: August 13, 2015
    Applicant: CELLTRION, INC.
    Inventors: Young Jun Park, Jin-kyo Jeong, Young Mi Choi, Min Seob Lee, Joon hun Choi, Eun Joo Cho, Hyunnam Song, Sung Jun Park, Jong-hyoup Lee, Seung Suh Hong